Abdominal Exploration Without Incisions

Sponsor
Jeffrey Hazey (Other)
Overall Status
Completed
CT.gov ID
NCT00427752
Collaborator
Stryker Nordic (Industry), Ethicon Endo-Surgery (Industry)
20
1
1
63
0.3

Study Details

Study Description

Brief Summary

This study is being conducted to determine whether an endoscope, (a small, flexible tube with a camera mounted on the end) passed down through the throat, through the stomach, and into the abdomen can safely and accurately examine the organs and tissue of the abdomen and take biopsies if needed. We wish to determine if this endoscopic diagnostic route is as efficient as the laparoscopic diagnostic route, which is currently the standard of care.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Transgastric endoscopic peritoneoscopy.
Early Phase 1

Detailed Description

We propose to investigate the efficacy of transgastric endoscopic peritoneoscopy with endoscopic biopsy in patients undergoing diagnostic laparoscopy and who will require a concurrent gastrotomy for placement of a PEG, gastrojejunostomy or gastric resection.

We hypothesize that diagnostic endoscopic peritoneoscopy can be done safely with adequate visualization of the abdominal cavity to direct clinical treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
Single (Investigator)
Primary Purpose:
Diagnostic
Official Title:
Diagnostic Transluminal Endoscopic Peritoneoscopy
Study Start Date :
Oct 1, 2006
Actual Primary Completion Date :
Jan 1, 2012
Actual Study Completion Date :
Jan 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Whipple

Patients with pancreatic cancer who will proceed to a Whipple procedure.

Procedure: Transgastric endoscopic peritoneoscopy.
Exploration of the abdominal area

Outcome Measures

Primary Outcome Measures

  1. 1) That transgastric endoscopic peritoneoscopy is feasible. [4/12]

Secondary Outcome Measures

  1. That bacterial abdominal contamination is not clinically significant. [04/11]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pancreatic Cancer undergoing staging laparoscopy

  • Staging or diagnostic laparoscopy in anyone needing enteral access

Exclusion Criteria:
  • Lack of consent

  • Intra-abdominal adhesions precluding diagnostic laparoscopy

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Ohio State University Center for Minimally Invasive Surgery Columbus Ohio United States 43210

Sponsors and Collaborators

  • Jeffrey Hazey
  • Stryker Nordic
  • Ethicon Endo-Surgery

Investigators

  • Principal Investigator: Jeffrey W Hazey, MD, Ohio State University
  • Principal Investigator: William S Melvin, MD, Ohio State University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jeffrey Hazey, Associate Professor, Ohio State University
ClinicalTrials.gov Identifier:
NCT00427752
Other Study ID Numbers:
  • 2006H0120
First Posted:
Jan 29, 2007
Last Update Posted:
May 7, 2012
Last Verified:
May 1, 2012
Keywords provided by Jeffrey Hazey, Associate Professor, Ohio State University

Study Results

No Results Posted as of May 7, 2012